Senti Biosciences Holdings, Inc.
Biological Products, (No Diagnostic Substances) · SOUTH SAN FRANCISCO · CA
Moderate confidence (50%)
Updated Oct 17, 2026, 12:04 AM
What is happening
Derived by rule set status-rules-2026.09.7
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
Latest material event: Senti Biosciences Holdings, Inc. received a delisting notice from its exchange (Aug 27, 2026)
Timeline
Every material event, newest first. History is never overwritten.
Senti Biosciences Holdings, Inc. received a delisting notice from its exchange
Aug 27, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On August 27, 2026, the Company received (1) a written notice (the Minimum Bid Price Notice ) from the Listing Qualifications Department of The Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that, for the last 30 consecutive trading days, the closing bid price of the Company s common stock, par value $0.0001 per share (the Common Stock ), had closed below the minimum bid price requirement of $1.00 per share for continued listing on The Nasdaq Capital Market pursuant to Nasd…”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Biological Products, (No Diagnostic Substances)
- Subindustry
- —
- Listing
- SEC lists the ticker SNTI on Nasdaq.
- SEC CIK
- 0001854270
- Website
- —
- —
- Headquarters
- SOUTH SAN FRANCISCO, CA
- Also known as
- Dynamics Special Purpose Corp., Senti Biosciences, Inc.
- Legal entities
- Senti Biosciences Holdings, Inc.
Sources
Every material source used to build this profile.
SEC Company Submissions (TIER 1 · UNVERIFIED)
Senti Biosciences Holdings, Inc. — Biological Products, (No Diagnostic Substances) (SIC 2836) — SOUTH SAN FRANCISCO, CA
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On August 27, 2026, the Company received (1) a written notice (the Minimum Bid Price Notice ) from the Listing Qualifications Department of The Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that, for the last 30 consecutive trading days, the closing bid price of the Company s common stock, par value $0.0001 per share (the Common Stock ), had closed below the minimum bid price requirement of $1.00 per share for continued listing on The Nasdaq Capital Market pursuant to Nasd…
View source record
Status history
Every derived status, with the rule that produced it.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:30 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:12 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:33 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 14, 2026, 04:44 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 02:39 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.